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Abstract
Background: Multiplicity and genetic diversity of Plasmodium falciparum infection might play a role in determining
the clinical outcome of malaria infection and could be a fair reflection of the disease transmission rate. This study
investigated the genetic diversity of P. falciparum and multiplicity of infection in relation to the severity of malaria
and age of patients in Gezira State, Sudan.
Methods: A cross-sectional health facilities-based survey was conducted in Gezira State, Sudan in January 2012. A
total of 140 P. falciparum malaria patients diagnosed with microscopy and confirmed using nested PCR were
recruited and classified into uncomplicated malaria and severe malaria states according to the standard WHO
criteria. DNA was extracted and MSP1 and MSP2 allelic families were determined using nested PCR.
Results: The overall multiplicity of infection (MOI) was 2.25 and 2.30 and 2.15 for uncomplicated and severe malaria
respectively. There were no statistically significant differences between uncomplicated and severe malaria (SM) patient
groups in MOI with regard to MSP1, MSP2 and overall MOI (Mann-Whitney U-test; all P < 0.05). The predominant MSP1
allelic families were MAD20 for uncomplicated malaria and RO33 for severe malaria. The distribution of both FC27 and
IC1/3D7 MSP2 allelic families were approximately the same across disease severity. One hundred and eleven P. falciparum
isolates (81 %) consisted of multiple genotypes; 71/90 (78.9 %) in uncomplicated malaria and 40/50 (85.1 %) in severe
malaria patient groups. Neither MSP1 nor MSP2 allelic families showed association with malaria severity. No statistically
significant differences in multiplicity of infection were observed between different age groups.
Conclusion: In this study the majority of P. falciparum isolates from uncomplicated and severe malaria patients consisted
of multiple genotypes. Further molecular epidemiological studies delineate the link between P. falciparum genotype with
the malaria phenotype in different regions are encouraged.
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Background
Malaria caused by Plasmoduim falciparum is a major
public health problem in sub-Saharan countries. In 2015
theglobal burden of the disease reached 214 million
cases with 97 countries and 3.2 billion people at risk [1].
In Sudan, malaria is a leading cause of morbidity and
mortality. High malaria transmission occurs in 87 % of
the population [2]. The peak months of malaria trans-
mission are from September to November. However, in
GeziraState there is an additional peak by the end of
February, which corresponds to the end of the irrigation
season when small pools of water form along the drying
canals with subsequent increase in mosquito density [3].
Malaria exhibits a wide range of clinical manifestations
ranging from asymptomatic parasitaemia, uncomplicated
(mild) to complicated (severe) disease [4]. Molecular epi-
demiological studies of malaria are used to investigate
the genetic diversity of infection with consideration of
various factors such as disease phenotype, age and host
immunity. Plasmodium falciparum is the most virulent
malaria parasite species. It exhibits a complex genetic
polymorphism which may explain its ability to present
with different clinical manifestations of the disease
spectrum [5]. Moreover, some have stated that certain P.
falciparum genotypes can be linked with more virulent
infections [6, 7], and the presence of multiple infections
may affect the release of different pro-inflammatory
cytokines, that makes it more difficult for the immune
system to deal with, resulting in severe malaria [8].
Molecular approaches helps to increase our understand-
ing of malaria epidemiology as well as clinical manifest-
ation [9]; these include molecular characterization of the
malaria parasite in order to answer why some patients de-
velop severe disease while others end up with mild form.
Merozoite Surface proteins 1 and 2 (MSP1 and MSP2) of
P. falciparum are major blood stage malaria surface anti-
gens [10]. They play a major role in erythrocyte invasion
by merozoite parasite [11]; therefore, they are targeted by
the immune response [12]. Also they are very suitable
markers for identification of genetically distinct parasite
sub-populations and investigation of the genetic diversity
of P. falciparum [13].
MSP1 gene is located on chromosome 9 and con-
tains 17 blocks of sequences, of which 7 are variable,
flanked by conserved regions [14]; block 2 is most
polymorphic and is grouped into three allelic families
MAD20, K1 and RO33 [15]. MSP2 gene is located on
chromosome 2 composed of five blocks of which the
central block 3 is the most polymorphic [16]. The
MSP2 alleles are grouped into two allelic families,
FC27 and IC1/3D7) [13].
Several studies have linked MOI to the severity of
malaria especially in areas with high transmission rates
[17, 18]. In this regard, determination of MOI in a highly
endemic area such as the Gezira State becomes crucial,
since it predicts clinical course target population with
higher attention (e.g. certain age groups). Regular mo-
lecular epidemiological surveys that monitor the genetic
diversity of P. falciparum populations in different re-
gions of the country as well as worldwide and linking
parasite genotypes to the disease phenotypes are cru-
cially important.
In this health care service-based study we aimed to in-
vestigate the genetic diversity of P. falciparum and
multiplicity of infection and their relationship to the dis-
ease severity and patient age.
Methods
Study area
The study was carried out in Wad-MadaniPediatric
Hospital (WPH), Wad-Madani teaching hospital (WTH)
and neighboring health facilities in Gezira State, located in
the center of Sudan. Gezira state lies on the west bank of
the Blue Nile. The geographical coordinates of the state
are 14°30'0"N, 33°30'0"E. Plasmodium falciparum is the
predominant species (prevalence 90–95 %), and the
Anopheles arabiensis is the main mosquito vector [19].
These health facilities were selected because of their high
malaria admission rate (they receive malaria patients from
all over the state) and good health infrastructure.
Patients and malaria definition
A total of 140 patients from those screened for malaria
during a cross-sectional study conducted in January 2012
were confirmed positive for P. falciparum malaria by mi-
croscopy and nested PCR. All age groups (from age 1 to
80 years) were targeted. Malaria patients were classified
into uncomplicated and severe malaria states according to
the WHO criteria [20]. Uncomplicated malaria patients
were defined as positive smear for P. falciparum and pres-
ence of fever (≥ 37.5 °C). Severe malaria patients were
having additional symptoms (e.g. convulsions, clinical
jaundice, respiratory distress, hyperpasitaemia and severe
anemia) [20]. Complicated and severe malaria patients
were admitted to the hospital and have been treated. Pa-
tients with uncomplicated malaria were recruited from
the hospital's general pediatric ward and from the out-
patient clinics. Intravenous blood samples (5 ml) were col-
lected in EDTA tubes (vacutainers) at admission before
the initiation of anti-malarial treatment. Demographical
data were recorded including age and sex.
Microscopy and parasite counts
Microscopic visualization of both thick and thin blood films
was prepared using 10 % Giemsa stain. The stained slides
were examined under a light microscope for detection and
identification of Plasmodium species and for parasite count.
Parasite density was determined by counting the number
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of asexual parasites per 200 white blood cells, and
calculated per microliter (μl) using the following for-
mula: number of parasites × 8,000/200, assuming a
white blood cell count of 8,000 cells per μl [21].
Extraction of parasite DNA
Genomic DNA was extracted from 100 μl blood samples
or from stored blood spotted on Whatman 3 filter paper
using 0.5 % Saponin (Sigma-Aldrich, Taufkirchen,
Germany) to free parasites from red blood cells followed
by Chelex® 100 (Bio-Rad Laboratories, California, USA)
method as described by Plowe et al. [22]. DNA was
checked for purity and quantity using Nanodrop spec-
trophotometer (ND 1,000), and stored at -20 °C until
used for PCR amplification.
Molecular identification, MSP1 and MSP2 genotyping
Plasmodium spp. were identified by 18S rRNA gene-
based nested PCR using genus- and species-specific
primers as described by Snounou et al. [23]. Plasmodium
falciparurm were further analyzed by two highly poly-
morphic regions of MSP1 (block 2) and MSP2 (block 3)
and their allelic types (MAD20, K1 and RO33) and
(FC27and IC1/3D7), respectively, using nested PCR [24].
In brief PCR reactions were carried out in a final volume
of 25 μl containing 2 μl of parasite DNA, 2 mM MgCl2,
0.2 mMdNTPs, 1 μl of each primer and 1 unit of Taq
Polymerase (Vivantis,SelangorDarulEhsan, Malaysia). Cyc-
ling conditions for the outer PCR were as follows:initial
denaturation at 94 °C for 3 min, followed by 37 cycles
of denaturation at 94 °C for 30 s, primer annealing at
55 °C for 1 min; and primer extension at 72 °C for
2 min. The final cycle had a prolonged extension at
72 °C for 10 min. PCR reactions were incubated in a
thermal cycler (SensoQuest, Göttingen, Germany). Al-
lelic specific positive control and DNA negative con-
trol were included in each set of reactions [25].
Detection of alleles
The amplified PCR products were analyzed by electrophor-
esis on 2 % molecular grade agarose gel (Caisson,Utah,
USA) and visualized by UV trans-illuminator (BioDoc-It
UVP, Cambridge, UK), following ethidium bromide stain-
ing. The number and size of DNA fragments was esti-
mated using 100 bp DNA ladder (Vivantis,Selangor
Darul Ehsan, Malaysia).
Multiplicity of infection
Multiplicity of infection (MOI) was determined by calcu-
lating the number of different alleles at each locus; single
infections were those with only one allele per locus at all
of the genotyped loci. Multiclonal infections were de-
fined as those having more than one allele in at least
one locus out of the loci genotyped.
Data analysis
Data were entered and analyzed using the software
Statistical Package for Social Sciences version 20 (SPSS,
Inc., Chicago, IL, USA). The MSP1 and MSP2 allelic
frequency was calculated. The mean multiplicity of in-
fection (MOI) was calculated for MSP1, MSP2 and over-
all MOI. Continuous variables were compared using
Spearman’s rank correlation coefficient. Dichotomous
variables were analyzed using Chi-square test. Mann-
Whitney U-test was used to compare the mean MOI ac-
cording to severity (disease phenotype). Different age
groups’ MOIs were calculated and the statistical signifi-
cance was tested using Kruskal-Wallis H-test. Statistical
significance level was defined as P-value ≤ 0.05 at 95 %
confidence interval.
Results
Plasmodium falciparum DNA was detected in all mal-
aria patients by nested PCR (Fig. 1). Across all age
groups, about two-thirds of malaria patients represented
Fig. 1 Gel electrophoresis picture for detection of 18S rRNA P.
falciparum gene: Lane 1, 100 bp DNA ladder; Lanes 2–5, 200 bp18S
rRNA gene; Lane 6, negative control
Table 1 Demographic and clinical data of uncomplicated and
severe malaria patients in Gezira state, Sudan, January 2012
Characteristic Uncomplicated
malaria (n = 90)
Severe malaria
(n = 50)
Age, mean (SD) 23.72 ± 16.69 19.30 ± 14.05
Male gender n (%) 55 (76.4) 22 (30.6)
Axillary temperature, mean (SD), °C 37.45 ± 1.29 38.97 ± 1.03




Hyperpasitaemia (≥50,000/μl of blood) 0 (0) 7 (14)
Respiratory distress (%) 0 (0) 19 (38)
Clinical jaundice n (%) 0 (0) 2 (4)
Convulsions 0 (0) 3 (6)
Mean of hemoglobin (g/dl) 12.84 ± 2.16 7.44 ± 2.16
Severe anemia (<5 g/dl) n (%) 0 (0) 2 (4)
Abbreviations: n number of individuals, SD standard deviation
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uncomplicated malaria cases and the remaining third
were categorized as severe malaria (SM) patients accord-
ing to the WHO classification. The demographic and
clinical data for both uncomplicated and severe malaria
patients are summarized in Table 1. All malaria patients
were treated using the standard WHO treatment proto-
col for malaria.
Genotyping of P. falciparum and multiplicity of infection
in uncomplicated and severe malaria patients
Polymorphism of MSP1 and MSP2 allelic families was
assessed in all blood samples. Allelic families were de-
tected in 114/140 (81 %) and 130/140 (92.86 %) samples
for MSP1 (Fig. 2) and MSP2 (Fig. 3), respectively.
The overall multiplicity of infection (MOI) was 2.25. The
overall MOI with regard to uncomplicated and severe mal-
aria cases were 2.30 (95 % CI: 2.12–2.48) and 2.15 (95 % CI:
1.94–2.36), respectively. However the differences in MSP1,
MSP2 and overall MOI were statistically non-significant
(Mann-Whitney U-test; U =1390.500, 1778.500 and 193
4.500, respectively; P = 0.826, 0.712 and 0.379, respectively)
(Table 2).
Allelic frequency and genetic diversity of P. falciparum in
uncomplicated and severe malaria patients
Allelic genotyping of MSP1 (MAD20, K1 and RO33)
and MSP2 (FC27 and ICI/3D7) allelic families showed
the polymorphic nature of the Sudanese P. falciparum
isolates with respect to disease phenotype (uncompli-
cated versus severe malaria patients). In uncomplicated
malaria patients, a total of 14 different-sized alleles for
MSP1 were detected compared to 21 different-sized al-
leles for MSP2 (Table 3).
In severe malaria patients, a total number of 12
different-sized alleles for MSP1 were detected compared
to 20 different-sized alleles for MSP2. The predominant
Fig. 2 Gel electrophoresis of MSP1 allelic types: Lane 1,100 bp DNA ladder; l. Lanes 2 and 3, 100 bp and 180 bp of MAD20; Lanes 4 and 5, 100 bp
and 220 bp of MAD20; Lane 6, negative control of MAD20; Lanes 7 and 8, negative samples of K1; Lanes 9 and 10, 180 bp and 200 bp of K1;
Lane 11, negative control of K1; Lanes 12–14, 160 bp of RO33; Lane 15, negative control of RO33
Fig. 3 Gel electrophoresis of MSP2 allelic types: Lane 1, 100 bp DNA ladder; Lanes 2–4, 300 bp and 350 bp of FC27; Lane 5, 500 bp and 550 bp
and of IC1/3D7; Lane 6, 500 bp of ICI/3D7; Lane 7, negative control
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MSP1 allelic families were MAD20 for the uncomplicated
malaria and RO33 for the severe malaria. The distribution
of both FC27 and IC1/3D7 MSP2 allelic families was ap-
proximately the same across disease severity. One hun-
dred and eleven P. falciparum isolates (81 %) consisted of
multiple genotypes; 71/90 (78.9 %) in uncomplicated mal-
aria and 40/50 (85.1 %) in severe malaria patients. Neither
MSP1 nor MSP2 allelic families showed association with
malaria severity. The frequency of the identified MSP1
and MSP2 allelic families across the uncomplicated and
severe malaria patients is shown in Table 3.
Multiplicity of infection, malaria phenotype, clonality of
isolates, parasite density and different distribution of
allelic families across different age groups
Approximately more than three-quarters of malaria
patients in all age groups were found to have a multi-
clonal P.falciparum infections (Table 4). Multiplicity
of infection was the highest (2.6, 95 % CI: 2.02–3.18)
in the youngest age group (< 5 year-old) (Table 4):
however the result wasnot statistically significant
(Spearman’s rank coefficient = 0.04; P = 0.658). There
was a statistically significant positive correlation be-
tween age and parasite density (Spearman’s rank coef-
ficient = 0.263; P = 0.046). The oldest age group
(> 40 year-old) had the highest mean parasite density
(24,357.8 parasites/μl) (Table 4). The distribution of
different MSP1 and MSP2 allelic families and their
different combinations are shown in Table 4. The dif-
ference in distribution was only significant for total
MSP2 (Chi-square Test, Χ2 = 8.673, P = 0.034).
Discussion
In Sudan, very few studies investigated the genetic diver-
sity and multiplicity of infection of P. falciaprum. To
our knowledge, this is the first study to provide data on
Table 2 Multiplicity of infection of MSP1 and MSP2 and overall
MOI in mild and severe malaria patients in Gezira State, Sudan
(January 2012)
Genes Uncomplicated
malaria (n = 90)
Severe malaria (n = 50) P-valueb
MOI (95 % CI) MOI (95 % CI)
MSP1 1.95 (1.73–2.16) 1.84 (1.61–2.07) 0.826
MSP2 1.90 (1.72–2.08) 1.83 (1.59–2.08) 0.712
Overall MOIa 2.3 (2.12–2.48) 2.15 (1.94–2.36) 0.379
Abbreviations: CI confidence interval, MOI multiplicity of infection
aDetermined by selecting the highest number of alleles detected in any of the
two antigens
bP-values from Mann-Whitney U-test
Table 3 MSP1, MSP2 genetic diversity, allelic frequency and allelic families fragment sizein mild and severe malaria patients in Gezira
State, Sudan (January 2012)
Uncomplicated malaria (n = 90) Severe malaria (n = 50)
Gene/Allele Positive n (%) Fragment size (bp) No. of alleles Positive n (%) Fragment size (bp) No. of alleles P-value*
MSP1
MAD20 16 (17.8) 100–380 7 3 (6) 100–300 7
K1 5 (5.6) 160–300 6 5 (10) 180–300 4
RO33 13 (14.4) 160 1 3 (6) 160 1
MAD20/K1 10 (11.1) 4 (8)
MAD20/RO33 14 (15.5) 8 (16)
K1/RO33 9 (10.0) 8 (16)
MAD20/K1/RO33 10 (11.1) 6 (12)
Total 77 (85.5) 14 37 (74) 12 0.326
Total MAD20 50 (55.5) 21 (42) 0.078
Total K1 34 (38.0) 23 (46) 0.343
Total RO33 46 (51.0) 25 (50) 0.724
MSP2
FC27 20 (22.2) 200–600 10 11 (22) 200–600 9
IC1/3D7 19 (21.1) 250–700 11 8 (16) 350–700 11
FC27/IC1/3D7 49 (54.4) 23 (46)
Total 88 (97.7) 21 42 (84) 20 0.002
Total FC27 69 (77.0) 34 (68) 0.265
Total IC1/3D7 68 (76.0) 31 (62) 0.091
*P-values using Chi-square test
Abbreviation: n number of individuals
Mahdi Abdel Hamid et al. Parasites & Vectors  (2016) 9:362 Page 5 of 8
the genetic diversity and multiplicity of P. falciparum
isolates in relation to disease phenotype based on MSP
antigen in Gezira State, Central Sudan. In our study
there was no association between MOI and malaria out-
come (severe versus uncomplicated) which is consistent
with other reports from Sudan [26], Ghana [27], Gabon
[28], Gambia [29] and Madagascar [30], but our results
differ from those reporting higher MOI in severe malaria
patients in Uganda [17] and India [18] and those report-
ing higher MOI in uncomplicated malaria patients in
Senegal [31] and Nigeria [32]. However the methodology
used in our study (due to our limited funds) is compara-
tively weak because variation in size at MSP loci may be
hard to interpret since multiple insertion-deletion muta-
tions, recombination events, and/or convergence due to
selection could generate alleles that differ at the se-
quence level but have the same fragment size or restric-
tion fragment length polymorphism pattern and the
results should be confirmed by DNA sequencing.
Our reported overall MOI (2.25) was higher than that ob-
served in Gadarif state, Sudan(overall MOI = 1.52) [26] and
lower than recorded in a study conducted in Mauritania
(overall MOI = 3.2) where malaria is hyperendemic [33].
This conflict of results is most likely due to inter-laboratory
variation which restricts comparison of MOI in different
settings [34].
In this study we found a remarkably high frequency of
multiclonal isolates (81 %) comparable to that (82.3 %)
reported in Mauritania [33]. The frequency of multiclo-
nal isolates was higher in severe compared to uncompli-
cated malaria patients (85.1 vs 78.9 %). This observation
is in agreement with the study of Shigidi et al. [35]
which reported 58.6 % and 35.6 % in severe and uncom-
plicated malaria patients, respectively, and in contrast to
the results of A-Elbasit et al. [26], who observerd 34 %
and 41 % in severe and uncomplicated malaria patients,
respectively. These differences in multiclonal infections
proportions could be attributed to different geographical
regions. It is interesting to note that the current study
was conducted after implementation of artemisinin com-
bination therapy (ACT) in Sudan [36]. In this study we
found no association between P. falciparum specific al-
lele families and clinical outcome and several studies
reached the same conclusion [17, 18, 26, 28, 30].
The observed increase in multiplicity of infection and
frequency of multiclonal isolates of P. falciparum in this
Table 4 Distribution of Plasmodium falciparum MSP1 and MSP2 allelic families and mean of parasite density among age groups of
uncomplicated and severe P. falciparum malaria patients in Gezira State, Sudan (January 2012)
Gene/Allele Age group (years)
<5 5–19 20–40 >40 Total
n (%) n (%) n (%) n (%) n (%)
(n = 16) (n = 53) (n = 52) (n = 19) (n = 140)
MSP1
MAD20 0 (0) 10 (18.9) 6 (11.5) 3 (15.8) 19 (16.7)
K1 1 (6.3) 4 (7.5) 4 (7.7) 1 (5.3) 10 (8.8)
RO33 1 (6.3) 4 (7.5) 11 (21.2) 0 (0) 16 (14.0)
MAD20/K1 3 (18.7) 3 (5.7) 5 (9.6) 3 (15.8) 14 (12.3)
MAD20/RO33 2 (12.5) 10 (18.9) 6 (11.5) 4 (21.0) 22 (19.3)
K1/RO33 0 (0) 4 (7.5) 9 (17.3) 4 (21.0) 17 (14.9)
MAD20/K1/RO33 4 (25.0) 7 (13.2) 3 (5.8) 2 (10.5) 16 (14.0)
Total 11 (68.8) 42 (79.2) 44 (84.6) 17 (89.4) 114 (100)
MSP2
FC27 2 (12.5) 13 (24.5) 11 (21.2) 5 (26.3) 31 (23.9)
IC1/3D7 3 (18.8) 10 (18.9) 9 (17.3) 5 (26.3) 27 (20.8)
FC27/IC1/3D7 8 (50.0) 24 (45.3) 31 (59.6) 9 (47.4) 72 (55.4)
Total 13 (10.0) 47 (36.2) 51 (39.2) 19 (14.6) 130 (100)
Multiclonal isolates 14 (87.5) 40 (80.0) 41 (78.9) 16 (84.2) 111 (79.3)
Mild malaria n (%) 10 (60.0) 32 (60.0) 35 (67.0) 13 (68.0) 90 (64.3)
Severe malaria n (%) 6 (40.0) 21 (39.0) 17 (32.0) 6 (31.0) 50 (35.7)
Overall MOI 2.6 2.1 2.2 2.4
Parasite density (no. of parasites/μl) 5,859.7 14,630.8 13,251.4 24,357.8
Abbreviations: n number of individuals, MOI multiplicity of infection
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study area compared to previous studies in Sudan could
be due to some of the following reasons: (i) the followed
treatment guidelines in Sudan using ACTas a treatment
regimen since 2004 [36] which doesnot affect parasite ma-
ture sexual stages in which the genetic re-assortments and
re-arrangements occur; (ii) missed treated malaria patient-
s;(iii) non-adherence to antimalarial drugs and/or eogra-
phical differences.
With regard to MSP1, inuncomplicated malaria patients
the predominant allelic family was MAD20, whearas in se-
vere malaria patients the predominant allelic family was
RO33. These results are in contrast to what was reported
by Bouyou-Akotet et al. in Gabon [28]. On the other hand
the distribution of MSP2 for both FC27 and IC1/3D7 was
approximately the same across the uncomplicated and se-
vere malaria patients which agrees with A-Elbasit et al.
[26] who obtained similar results in Sudan. These differ-
ences are interpreted cautiously as study areas are differ-
ent which poses different malarial endemicity.
The current study found no association between multi-
plicity of infection and patients’ age group. This is in
agreement with previous studies conducted in Muritania
[33], Senegal [31] and Benin [37]. However, this finding
contrasts with reports from other locations in Burkina
Faso [38], Senegal [31] and Tanazania [39]. Previous stud-
ies on the varaiation of multiplicity of infection with re-
gard to agedistribution highlighted that the effect of age
on the multiplicity of infection is considerably affected by
the endemicity of malaria which is most likely a reflection
of the development of antiparasite specific immunity [40].
Conclusions
In this study the multiplicity of infection was comparable
between uncomplicated and severe malaria patients. The
multiplicity of infection and the distribution of multiclonal
isolates of P. falciparum were higher than previous studies
in Sudan. Neither MSP1 nor MSP2 allelic families exhib-
ited significant association with malaria severity. There
was no statistically significant difference between different
age groups with regard to the multiplicity of infection.
The observed high multiclonal isolates may facilitate the
spread of resistant strains with time. Further molecular
epidemiological studies that would help delineate the link
between P. falciparum genotypes with the malaria pheno-
types in different regions are encouraged.
Abbreviations
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